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Introduction: The breast and salivary gland tissue share embryologic and thus pathological similarities.
Acinic cell carcinoma (ACC) is a typical tumor in salivary glands, but rarely arises in breast too. We
reviewed 38 cases of mammary ACC reported in literature and our case, the ﬁrst ACC born within a
ﬁbroadenoma.
Materials and methods: Data were collected by a research for the key words acinic cell carcinoma breast
on Pubmed in March 2014, including a case treated in our department. All reviewed cases were
compared for clinical approach and histological pattern.
Results: To date 23 articles presenting cases of ACC of the breast are reported in literature. We included
in our review 38 cases previously described and one new case. The histological pattern was predomi-
nantly solid with a microglandular structure. All the tumor cells were cytologically characterized by
monotonous round cells with a ﬁnely granular, weakly eosinophilic, or clearly vacuolated cytoplasm. The
most of the cells were intensely stained with anti-lysozime, anti-amylase, anti-a1-chimotripsin, anti-
EMA and anti-S100 protein antisera. Immunohistochemistry was also performed to point out: estro-
gen receptor (ER), progesterone receptor (PR), androgen receptors (AR), human epidermal growth factor
receptor 2 overexpression (HER2/neu), E-cadherin (E-cad), cytokeratin-7 (CK7), gross cystic disease ﬂuid
protein 15 (GCDFP15), smooth muscle actin (SMA).
Conclusion: ACC of the breast is a rare tumor, showing similarities with the salivary gland counterpart,
above all in terms of good prognosis, and differences from the ordinary invasive breast carcinoma.
Further investigations are needed to elucidate the true histogenesis and the correct treatment.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Background
The breast and salivary gland tissues share embryologic simi-
larities. They are both tubuloacinar exocrine glands with similar
histological features and consequently, some types of neoplasms
may originate indistinctively in either tissue. Tumors arising in the
breast gland and the salivary glands show similar morphological
features, but they differ in incidence and clinical behavior
depending onwhether they are primary in breast or salivary glands
[1].
Since the ﬁrst case of ACC of the breast was described by Ron-
caroli et al. [2] in 1996, several cases have been reported inedicine and Surgery, Breast
, 80131 Naples, Italy.
.
by Elsevier Ltd. All rights reservedliterature. The most of articles written about ACC are case reports,
sometimes associated to partial review. We have found 38 cases
described in international literature. This review discusses clinical
and pathological features of ACC described in literature. One case of
ACC of the breast has been treated in our department.2. Materials and methods
Data were collected by a research for the key words acinic cell
carcinoma breast on Pubmed in March 2014, including a case
treated in our department. All studies we found were analyzed to
include case reports of ACC of the breast, whose diagnosis had been
conﬁrmed by immunohistochemical ﬁndings, excluding misdiag-
nosis retrospectively confuted and the same cases described in
partial review of the literature. We reported in Tables 1 and 2
clinical and pathological features of ACC described in the.
Table 1
Clinical characteristics of acinic cell carcinomas of the breast reported in literature.
References Sex/age Site Tumor size
(mm)
Node status Surgery Adjuvant therapy Follow-up (months) Recurrences/metastases
Roncaroli et al. [2] (1996) F/42 R uoq 30 1/18 MRM þ ALND CT 60 e
Schimao et al. [3] (1998) M/23 L 48  42 na BCS þ ALND e 34 e
Damiani et al. [4] (2000) F/35 R uoq 40 2/20 MRM þ ALND Neo-CT 12 e
F/63 L 50 na BCS e 48 Local
F/55 L 20 na BCS e Lost na
F/64 L uiq 33 0/8 BCS þ ALND e 12 e
F/80 R uoq 20 na BCS HT 12 e
Schmitt et al. [5] (2000) F/79 na 45 0/23 MRM þ ALND RT 21 e
Coyne and Dervan [6] (2002) F/49 R 20 2/11 MRM þ ALND Neo-CT þ Ad-CT 36 liver
Elster et al. [7] (2002) F/48 na 30 0/6 BCS þ ALND CT þ RT na na
Hirokawa et al. [8] (2002) F/20 R 25  27 0 MRM þ ALND e 6 e
F/61 L 25 0 MRM þ ALND e 24 e
F/59 R 10 0 MRM þ ALND e 84 e
Kahn et al. [9] (2003) F/56 L 22 0/18 MRM þ ALND e 28 e
Peintinger et al. [10] (2004) F/36 R 35  35 0/15 BCS þ ALND CT þ RT 120 Lung
Kinkor et al. [11] (2005) F/70 na na na na na na na
F/40 na na na na na na na
Tanahashi et al. [12] (2007) F/80 R 21  14 0/1 MRM þ SLND e 22 e
Reis-Filho et al. [13] (2008) Six cases na na na na na na na
Stolnicu et al. [14] (2010) F/79 L uoq 25  20 10/15 MRM þ ALND e 9 e
Huo et al. [15] (2011) F/40 R uoq 36  29  24 1/21 MRM þ ALND Neo-CT þ RT þ HT 12 e
F/30 R 26 2/33 BCS þ ALND CT þ RT 34-died Bone metastases
Chang et al. [16] (2011) F/39 na 55  30 1/not known BCS þ ALND e na na
Choh et al. [17] (2012) F/79 Lupper pole 27 0/1 BCS þ SLND RT 9 e
Sakuma et al. [18] (2012) F/61 R uoq 14  13 0 BCS þ ALND e 14 e
Zhao et al. [19] (2013) F/38 R uoq 30 0/23 MRM þ ALND CT 10 e
Shingu et al. [20] (2013) F/41 L 35  30  20 0/1 BCS þ SLND CT þ RT 36 e
Osako et al. [21] (2013) F/50 na 52 0/30 MRM þ ALND e 184.8 e
F/37 na 22 0/23 BCS þ ALND e 139.2 e
F46 na 50 0/4 MRM þ SLND e 64.8 e
Winkler et al. [22] 2013) F/56 R NMLE 40  29 0/1 MRM þ SLND Neo-CT þ HT 24 e
Ripamonti et al. [23] (2013) F/44 L uoq 13 0/2 MRM þ SLND HT 19 e
Falleti et al. [24] (2013) F/58 R peri-areolar 30 0/1 BCS þ SLND e na na
Present case F/26 R lqu 16  12  10 0/1 BCS þ SLND e 8 e
Abbreviations: uoq: upper outer quadrant, uiq: upper inner quadrant, lqu: lower quadrant union, MRM: modiﬁed radical mastectomy, BCS: breast conserving surgery, ALNA:
axillary lymph node dissection, SLNA: sentinel lymph node dissection, CT: chemotherapy, Neo-CT: neo-adjuvant chemotherapy, HT: hormone therapy, na: not available.
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tumor size and follow-up. We collected data about: surgical treat-
ment, in terms of Modiﬁed Radical Mastectomy (MRM) or Breast
Conserving Surgery (BCS such as lumpectomy or quadrantectomy),
axillary treatment, in terms of Axillary Lymph Node Dissection
(ALND) or Sentinel Lymph Node Dissection (SLND), neo-
adjuvant(Neo-CT) or adjuvant chemotherapy (CT) or hormonal
therapy (HT), and radiation therapy (RT). Recurrences and metas-
tases, in terms of onset time and location, were annotated. The
more applied immunohistochemical reactivity was registered as
positive or negative staining or not available, when not described
by authors. All reviewed cases were compared for clinical approach
and histological pattern.
3. Results
We included in our review 23 articles from 1996 to 2013, pre-
senting at least one case report of ACC of the breast [2e24]. In three
of these studies a review of the literature was associated, referring
to one [24], ﬁve [20], eight [19] and ten [20] previous reports. We
collected a total of 39 patients, affected by ACC of the breast. Only
one patient was a man [3]. Two cases described by Kinkor et al. [11]
in Czech are not fully analyzed, while six cases considered by Reis-
Filho et al. [13] have only been studied for the presence of t (12; 15)
ETV6-NTRK3 translocation, so neither clinical or pathological data
are reported. The clinicopathological features of 39 cases of primary
acinic cell carcinoma of the breast are presented in Tables 1 and 2.
The age of all patients, whose data are available, ranged from 20 to
80 years (mean age: 51 years). Tumor size ranged from 10 to 55mmin the greatest axis (mean value: 30.5 mm). All 39 patients, whose
clinical features are reported in Table 1 were treated surgically, 16
with MRM and 15 with BCS such as lumpectomy or quad-
rantectomy. Axilla was treated in 29 cases. In 21 patients ALND, in 8
patients SLND was performed. The node status was reported in 22
cases, in 7 cases at least one node was positive for metastases. In 4
cases neo-adjuvant chemotherapy was performed prior to surgery.
In 10 patients adjuvant therapy was reported: seven of them had
CT, other four HT. In 6 cases radiation therapy (RT) followed surgery
(Table 1). Follow-up was available in 26 patients and the longest
follow-up period was 184.8 months (range: 6e184.8 months).
Recurrence occurred in one patient after lumpectomy. Three pa-
tients reported metastases: one occurring in the liver, one in the
lung and one in bone after 12, 96 and 34 months after surgery,
respectively. Apart from one patient who developed liver metas-
tases, and died of disease three years after diagnosis, none of the
other patients with follow-up has died of disease.
The histopathological features of the same 39 cases of ACC are
reported in Table 2. The histological pattern was predominantly
solid with a microglandular structure, in four cases a cystic or/and
papillary components were associated [8,11,21]. All the tumor cells
were cytologically closely similar to each other, characterized by
monotonous round cells with a ﬁnely granular, weakly eosinophilic,
or clearly vacuolated cytoplasm. The coarse bright granules were
electron-dense and consistent with zymogen granules, sized from
0.08 to 0.9 mm. Mitochondria and granular endoplasmic reticulum
were abundant.
Immunohistochemistry was performed using some common
antibodies, but not always the same in each study. 26 cases were
Table 2
Immunohistochemical characteristics of acinic cell carcinomas of the breast reported in literature.
References Sex/age LYS AMY a1-ACT S-100 EMA ER PR AR Her2 E-cad Ck 7 GCD FP15 SMA
Roncaroli et al. [2] (1996) F/42 þ na þ þ þ    na na na na 
Schimao et al. [3] (1998) M/23 þ þ þ þ þ þ na na na na na na na
Damiani et al. [4] (2000) F/35 þ þ þ þ þ    na na na na 
F/63 þ þ þ þ þ    na na na þ 
F/55 þ þ þ þ þ    na na na na 
F/64 þ þ þ þ þ    na na na þ 
F/80 þ þ þ þ þ    na na na na 
Schmitt et al. [5] (2000) F/79 þ na na  þ   na  na na na 
Coyne and Dervan [6] (2002) F/49 þ na þ þ na na na na na na na na na
Elster et al. [7] (2002) F/48 þ na na þ þ   na  na na na 
Hirokawa et al. [8] (2002) F/20 þ þ þ þ na  na na na na na  na
F/61 þ þ þ þ na þ na na na na na þ na
F/59 þ þ þ þ na þ na na na na na þ na
Kahn et al. [9] (2003) F/56 þ na na þ þ na na na na na na na na
Peintinger et al. [10] (2004) F/36 þ na þ þ þ    na na na na na
Kinkor et al. [11] (2005) F/70 þ na na na na na na na na na na na na
F/40 þ na na na na na na na na na na na na
Tanahashi et al. [12] (2007) F/80  þ na  na   na  na þ  na
Reis-Filho et al. [13] (2008) 6 cases na na na na na na na na na na na na na
Stolnicu et al. [14] (2010) F/79 þ na na na na  þ þ  þ na þ na
Huo et al. [15] (2011) F/50 na na na þ þ þ  na  na na na 
F/30 na na na þ na   na  na na na na
Chang et al. [16] (2011) F/39 þ na þ þ þ   na  þ þ  
Choh et al. [17] (2012) F/79 na na na na na na na na na na na na na
Sakuma et al. [18] (2012) F/61 na þ þ  þ þ þ na  na na na na
Zhao et al. [19] (2013) F/38 þ n  þ þ   na  na na þ na
Shingu et al. [20] (2013) F/41 þ  þ þ þ   na  na na na na
Osako et al. [21] (2013) F/50 þ þ na þ na   na  na na na na
F/37 þ þ na þ na   na  na na na na
F46 þ þ na þ na   na  na na na na
Winkler et al. [22] 2013) F/56 na na na na na   na  na na na na
Ripamonti et al. [23] (2013) F/44 na na þ þ þ    na na na  
Falleti et al. [24] (2013) F/58 þ þ þ þ þ  þ     þ 
Present case F/26 þ þ þ þ na   na na þ þ na 
Abbreviations: LYS: lysozyme, AMY: amylase, a1-ACT: a1 anti-chimotrypsin/trypsin, S-100: S-100 protein, EMA: epithelial membrane antigen, ER: estrogen receptor, PR:
progesterone receptor, AR: androgen receptor, Her2:, human epidermal growth factor receptor 2, E-cad: E-cadherin, Ck 7: cytokeratin 7, SMA: smooth muscle actin, na: not
available.
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intensely stained with anti-amylase (AMY), only one not. 18 cases
showed positivity for a1-antichimotripsin/tripsin (a1-ACT), only
one not. S-100 protein was found in 25 cases, but three cases were
not stained. Epithelial membrane antigen (EMA) was present in 18
cases, negative in no one studied. 5 cases resulted positive for es-
trogen receptor (ER), 3 for progesterone receptor (PR), only one
case showed positivity for androgen receptors (AR), 3 tumors
showed positive immunoreactivity for E-cadherin, other 3 for
Cytokeratin-7 (CK7). 4 previous reports showed focal positivity for
gross cystic disease ﬂuid protein 15 (GCDFP15). Human epidermal
growth factor receptor 2 overexpression (HER2/neu) and smooth
muscle actin (SMA), when studied, were absent.
4. Discussion
ACC is a rare histological type of malignant epithelial neoplasms
characterized by widespread acinar cell-like differentiation. The
typical location are major and minor salivary glands, but ACC has
been occasionally reported in other organs, such as stomach, lung,
pancreas, liver, retroperitoneum, lacrimal glands and breast
[2,25e33]. ACC is listed in the 2003 World Health Organization
(WHO) classiﬁcation of tumors of the breast as invasive breast
carcinoma. Salivary gland-like tumors represent approximately 2%
of primary breast carcinomas. These lesions of the breast can be
subdivided into two main groups: tumors with diffuse or scanty
myoepithelial differentiation, the last ones include: ACC, oncocytic
carcinoma and mucoepidermoid carcinoma. ACC of the breast is
similar to its salivary gland counterpart at the morphological,immunohistochemical and ultrastructural aspects. Anyway some
differences should be noted: salivary ACC are circumscribed, with
pushing borders, solid and cystic areas, while breast ACC are less
circumscribed and inﬁltrating [1,34].
The ACC of the breast was ﬁrst described in 1996 by Roncaroli
et al. [2], and since then, several such cases have been reported.
Hitherto we have found 38 cases of ACC described in literature
[3e24] and one has been diagnosed in our department. Over time
the diagnosis have been more and more deﬁned, so that 6 cases of
these were diagnosed as ACC retrospectively. Hirokawa et al. [8]
demonstrated features of acinar cell differentiation in three secre-
tory carcinoma of the breast, suggesting that a considerable num-
ber of ACC might have been overlooked. Osako T. et al. [21]
reviewed a series of 19 cases diagnosed initially as secretory car-
cinoma using a panel of four markers (ETV6 rearrangement,
amylase, a-lactalbumin and adipophilin) for distinguishing secre-
tory carcinoma, ACC, cystic hypersecretory carcinoma and invasive
ductal carcinoma, so that three amylase positive tumors (negative
for other markers) were reclassiﬁed as ACC.
According to reviewed articles, diagnostic tools could not be
compared among the 39 cases analyzed, ﬁrst because from 1996 a
lot of things have changed in the management of breast cancer,
such as the spreading of ultrasound and then of MRI, or micro-
histological biopsy. Nevertheless even if the presence of acinic
cell at the ﬁne needle cytology could suggest the serous acinar
differentiation, the imaging could confound the diagnosis showing
a well-deﬁned mass or even a common inﬁltrating lesion, easily
associated to a common ductal invasive carcinoma [12,16,18].
Maybe a micro-biopsy could led to a deﬁnitive diagnosis
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ACC. As regards the therapeutic course the comparison among ar-
ticles written along an eighteen years-period is difﬁcult. The
approach seems to be regulated on the basis of the clinical staging
as for an invasive breast cancer is, but the impact on prognosis is
not so clear. The only case with local recurrence was treated by BCS
without any adjuvant therapy [4]. Nevertheless two cases devel-
oping liver and metastases had been treated radically with adju-
vant CTand neo-CT [6] or RT [10], respectively. Another case treated
conservatively showed bone metastases, but after 34 months. No
information about further treatment of these metastatic cases have
been reported [35]. According to these data it is not possible to trace
a way to follow. Although metastases and recurrences exist, their
rates is so low that the prognosis of the breast acinic cell carcinoma
can be considered good.
The most difﬁcult aspects of diagnosis of ACC are the rarity of
this pathology, the best-known behavior of ACC localized in salivary
glands, the differential diagnosis with secretory carcinoma of the
breast, the dilemma between good prognosis and common inﬁl-
trating microglandular pattern. The differential diagnosis with
microglandular adenosis and granular cell carcinomas (apocrine
carcinomas, oncocytomas and neuroendocrine carcinomas) is
based on morphological, immunohistochemical and ultrastructural
features [4].
Four cases of ACC arose in a background of Microglandular
Adenosis (MGA) [9,10,15,24]. According to the literature the re-
lationships between ACC, microglandular adenosis and micro-
glandular adenosis-associated lesions remains unclear. MGA is a
well-known benign breast lesion that has been reported in asso-
ciation with breast cancer in up to 27% of cases [36,37]. Previous
reports have shown that the pathogenesis of ACC is related to MGA.
Even if coarse bright eosinophilic cytoplasmic granules are present
both inMGA-associated lesions and ACC, each of these lesions show
a typical feature. Microglandular carcinoma show chondroid
metaplasia, absent in ACC. Similar to carcinoma arising inMGA, ACC
has a microglandular pattern, cytoplasmic granules and diffuse
immunoreactivity for S-100 protein. However, ACC is also positive
for EMA, lysozyme, amylase and a1-antichymotripsin. While the
glands in typical and atypical MGA are surrounded by basal lamina,
the neoplastic glands in ACC are not so [4,8,9,13,37].
These last features best link ACC to invasive ductal carcinoma.
The cases described by Kinkor [11] andWinkler [22] showed breast
invasive carcinoma with serous acinar differentiation, simulating
ACC. The association of acinic cells to intraductal low-grade
component [11,14], sharing ACC morphological and immunohisto-
chemical characteristics, could suggest the origin of this tumor
from a pre-invasive lesion.
With regard to the immunohistochemical ﬁndings (Table 2), the
most of the cells in almost all tumors were intensely stained with
anti-lysozyme, anti-amylase, anti-a1-chimotripsin, anti-EMA and
anti-S100 protein antisera. Amylase, lysozyme and a1-chimotripsin
were components of salivary gland acinar cells and the ﬁrst two
enzymes are virtually absent in ordinary breast cancer. A common
“triple negativity” for ER, PR and Her2/neu should suggest the
possibility of a breast cancer a quite different from ordinary, such as
salivary gland-like tumors [34].
The cases reviewed showed sometimes uncommon negativity
for lysozyme, for amylase, for S-100 [5,12,18,20]. Otherwise in some
cases strange positivity for ER, PR or AR could confound the diag-
nosis. Positivity to GCDFP15 could suggest an apocrine differenti-
ation associated to ACC. Interestingly Zhao et al. [19] found a
positivity for neuron-speciﬁc enolase (NSE) in their case of breast
ACC, thus giving space to differential diagnosis with neuroendo-
crine tumors, where chromogranin and synaptophysin stain were
positive too.Huo et al. [15] reported three cases of breast carcinomas pre-
senting prominent coarse eosinophilic cytoplasmic granules remi-
niscent of those in intestinal Paneth cells, but only two cases
showed areas of acinic carcinoma-like features. They conclude that
prominent coarse eosinophilic granules are a rare and nonspeciﬁc
feature in breast epithelium.
A recent study by Ripamonti et al. [23] described the ﬁrst case of
ACC of the breast occurring in a BRCA 1 mutation carrier, according
to previous studies, they suggest the notion that rare histological
types of breast, such as malignant phylloides tumor, atypical
medullary carcinoma and metaplastic breast carcinomas can occur
in patients with BRCA 1 mutations.
The history of neo-CT in 4 of the cases reviewed gives origin to
the question of the relationship between granules and therapy. In
the ﬁrst reported case information regarding the granules in pre-
treatment tumor was not available [4]. In a more recent study the
cytoplasmic granularity was greatly reduced after neo-CT [6], in
other studies represented the predominant component of the re-
sidual tumor suggesting a granular cell resistance or therapy
induced granularity [4,22].
Our case present the third youngest patient among the cases
reviewed and is the only one describing an association with a
ﬁbroadenoma. Neverthelesswe could not establish if its true origin is
in or out from the ﬁbroadenoma. Some cases of ACC of the breast lack
a ﬁbrous capsule, but could inﬁltrate or not the surrounding breast
tissue. In correspondence of the less differentiated component, our
case showed an extensive inﬁltration of the sclerotic stroma forming
the ﬁbroadenoma. No true ﬁbrous capsule was formed, but only a
thin collagen stripe surrounding more differentiated acinic cells was
evident. Other cases contained intraductal carcinoma with comedo-
type necrosis [2,16], but not our case. Immunohistochemical features
are similar to other reported cases, it showed a common absence of
hormonal receptor and myoepithelial differentiation. Nevertheless
an uncommon positivity for pan-cytokeratin, cytokeratin 7, E-cad-
herin and focally for vimentin was observed.
These results suggest that further investigations are required to
elucidate the histogenesis of mammary ACC, thus the guidelines for
diagnosis and treatment. This review is the ﬁrst to collect 23 articles
and present 39 cases of ACC; only case reports, eventually combined
to a partial review, have been published previously. The limits of this
review are linked to the limited sources, because all data have been
collected on websites; to the data not fully comparable, because of
the lack of complete clinical features; to the dissimilarity in diag-
nostic and immunohistochemical testing applied.
5. Conclusions
ACC of the breast is a rare tumor, similar to its salivary gland
counterpart regarding the morphological, immunohistochemical
and ultrastructural aspects, but it not always shares the same
benign behavior. The constant negativity for hormone receptor
signs a great difference from the ordinary breast carcinoma, so
perhaps different therapeutic strategies should be proposed. We
reviewed 39 cases of ACC sharing typical pathologic characteristics,
but no accordance in clinical management was found. We added an
interesting case of mammary ACC for the concomitant presence of a
ﬁbroadenoma, forming a unique lesion. By comparison we note
several similarities with previously described tumors, but we sug-
gested no adjuvant therapy and the prognosis seems to be good.
Further studies are needed to better understand the origin and the
correct treatment of the ACC arising in the breast.
Funding
All authors have no source of funding.
G. Limite et al. / International Journal of Surgery 12 (2014) S35eS39 S39Ethical approval
Ethical approval was requested and obtained from the Univer-
sity of Naples Federico II ethical committee.
Conﬂicts of interest
All Authors have no conﬂict of interests.
Author contribution
Limite Gennaro: Participated substantially in conception,
design, and execution of the study and in the analysis of data,
reviewing the manuscript.
Di Micco Rosa: Participated substantially in conception, design,
and execution of the study and in the analysis and interpretation of
data; also participated substantially in the drafting and editing of
the manuscript.
Esposito Emanuela: Participated substantially in the analysis
and interpretation of data, reviewing the manuscript.
Sollazzo Viviana: Participated substantially in the analysis and
interpretation of data.
Cervotti Maria: Participated substantially in the analysis and
interpretation of data.
Pettinato Guido: Participated substantially in analysis and
interpretation of pathologic and immunohistochemical data; he
also contributed to edit ﬁgures.
Varone Valeria: Participated substantially in analysis and inter-
pretation of pathologic and immunohistochemical data; she also
contributed to edit ﬁgures.
Benassai Giacomo: Participated substantially in the analysis and
interpretation of data.
Amato Bruno: Participated substantially in reviewing the
manuscript.
Pilone Vincenzo: Participated substantially in the analysis and
interpretation of data.
Luglio Gaetano: Participated substantially in reviewing the
manuscript.
Vitiello Antonio: Participated substantially in the analysis and
interpretation of data.
Hasani Ariola: Participated substantially in reviewing the
manuscript.
Liccardo Filomena: Participated substantially in the analysis and
interpretation of data.
Forestieri Pietro: Participated substantially in reviewing the
manuscript.
References
[1] M.1 Pia-Foschini, J.S. Reis-Filho, V. Eusebi, S.R. Lakhani, Salivary gland-like
tumours of the breast: surgical and molecular pathology, J. Clin. Pathol. 56
(7) (2003 Jul) 497e506.
[2] F. Roncaroli, J. Lamovec, A. Zidar, V. Eusebi, Acinic cell-like carcinoma of the
breast, Virchows Arch. 429 (1) (1996 Sep) 69e74.
[3] K.1 Shimao, S. Haga, T. Shimizu, et al., Acinic cell adenocarcinoma arising in
the breast of a young male: a clinicopathological, immunohistochemical and
ultrastructural study, Breast Cancer 5 (1) (1998 Jun 30) 77e81.
[4] S. Damiani, G. Pasquinelli, J. Lamovec, J.L. Peterse, V. Eusebi, Acinic cell car-
cinoma of the breast: an immunohistochemical and ultrastructural study,
Virchows Arch. 437 (1) (2000 Jul) 74e81.
[5] F.C. Schmitt, C.A. Ribeiro, S. Alvarenga, J.M. Lopes, Primary acinic cell-like
carcinoma of the breastea variant with good prognosis? Histopathology 36
(3) (2000 Mar) 286e289.
[6] J.D. Coyne, P.A. Dervan, Primary acinic cell carcinoma of the breast, J. Clin.
Pathol. 55 (7) (2002 Jul) 545e547.
[7] E.A. Elster, J. Markusic, R. Ball, et al., Primary acinic cell carcinoma of the
breast, Am. Surg. 68 (11) (2002 Nov) 993e995.
[8] M. Hirokawa, K. Sugihara, T. Sai, et al., Secretory carcinoma of the breast: a
tumor analogous to salivary gland acinic cell carcinoma? Histopathology 40
(3) (2002 Mar) 223e229.[9] R. Kahn, H. Holtveg, F. Nissen, S. Holck, Are acinic cell carcinoma and micro-
glandular carcinoma of the breast related lesions? Histopathology 42 (2)
(2003 Feb) 195e196.
[10] F. Peintinger, S. Leibl, R. Reitsamer, F. Moinfar, Primary acinic cell carcinoma of
the breast: a case report with long-term follow-up and review of the litera-
ture, Histopathology 45 (6) (2004 Dec) 645e648.
[11] Z. Kinkor, A. Skalova, Acinic cell-like differentiation in invasive ductal carci-
noma and in ductal hyperplasia of the breastereport of two cases, Cesk Patol.
41 (1) (2005 Jan) 29e33.
[12] C. Tanahashi, S. Yabuki, N. Akamine, Y. Yatabe, S. Ichihara, Pure acinic cell
carcinoma of the breast in an 80-year-old Japanese woman, Pathol. Int. 57 (1)
(2007 Jan) 43e46.
[13] J.S. Reis-Filho, R. Natrajan, R. Vatcheva, et al., Is acinic cell carcinoma a variant
of secretory carcinoma? A FISH study using ETV6'split apart' probes, Histo-
pathology 52 (7) (2008 Jun) 840e846 (Epub 2008 May 6).
[14] S. Stolnicu, M. Dohan, O. Preda, et al., Primary acinic cell carcinoma of the
breast associated with an intraductal cell component, Patología 48 (3) (2010)
204e207.
[15] L. Huo, D. Bell, H. Qiu, A. Sahin, Y. Wu, N. Sneige, Paneth cell-like eosinophilic
cytoplasmic granules in breast carcinoma, Ann. Diagn. Pathol. 15 (2) (2011
Apr) 84e92 (Epub 2010 Dec 16).
[16] E.D. Chang, E.J. Lee, A.W. Lee, J.S. Kim, C.S. Kang, Primary acinic cell carcinoma
of the breast: a case report with an immunohistochemical and ultrastructural
studies, J. Breast Cancer 14 (2) (2011 Jun) 160e164 (Epub 2011 Jun 18).
[17] C.T. Choh, V. Komar, S.P. Courtney, Primary acinic cell carcinoma of the breast:
a rare lesion with good prognosis, Breast J. 18 (6) (2012 Nov-Dec) 610e611
(Epub 2012 Sep. 25).
[18] T. Sakuma, A. Mimura, N. Tanigawa, R. Takamizu, Fine needle aspiration
cytology of acinic cell carcinoma of the breast, Cytopathology 24 (6) (2013
Dec) 403e405 (Epub 2012 Jun 26).
[19] Y. Zhao, W. Li, R. Lang, et al., Primary acinic cell carcinoma of the breast: a case
report and review of the literature, Int. J. Surg. Pathol. 22 (2) (2014 Apr)
177e181.
[20] K. Shingu, T. Ito, G. Kaneko, N. Itoh, Primary acinic cell carcinoma of the
breast: a clinicopathological and immunohistochemical study, Case Rep.
Oncol. Med. 2013 (2013) 372947 (Epub 2013 Sep. 26).
[21] T. Osako, K. Takeuchi, R. Horii, T. Iwase, F. Akiyama, Secretory carcinoma of
the breast and its histopathological mimics: value of markers for differ-
ential diagnosis, Histopathology 63 (4) (2013 Oct) 509e519 (Epub 2013
Aug 14).
[22] N. Winkler, G. Morrell, R.E. Factor, Invasive carcinoma with acinic cell-like
features of the breast, Breast J. 19 (3) (2013 May-Jun) 334e335 (Epub 2013
Apr 18).
[23] C.B. Ripamonti, M. Colombo, P. Mondini, et al., First description of an acinic
cell carcinoma of the breast in a BRCA1 mutation carrier: a case report, BMC
Cancer 13 (2013 Feb 1) 46.
[24] J. Falleti, G. Coletti, E. Rispoli, et al., Acinic cell carcinoma of the breast arising
in microglandular adenosis, Case Rep. Pathol. 2013 (2013) 736048 (Epub 2013
Nov 28).
[25] H.T. Hoffman, L.H. Karnell, R.A. Robinson, J.A. Pinkston, H.R. Menck, National
cancer data base report on cancer of the head and neck: acinic cell carcinoma,
Head Neck 13 (1999) 297e309.
[26] N.G. Ordo~nez, Pancreatic acinar cell carcinoma, Adv. Anat. Pathol. 13 (2001)
144e159.
[27] K.D. Holen, D.S. Klimstra, A. Hummer, et al., Clinical characteristics and out-
comes from an institutional series of acinar cell carcinoma of the pancreas and
related tumors, J. Clin. Oncol. 13 (2002) 4673e4678.
[28] G. De Rosa, P. Zeppa, F. Tranfa, G. Bonavolonta, Acinic cell carcinoma arising in
a lacrimal gland. First case report, Cancer 13 (1988) 1988e1991.
[29] J. Rodriguez, J. Diment, L. Lombardi, F. Dominoni, W. Tench, J. Rosai, Combined
typical carcinoid and acinic cell tumor of the lung: a heretofore unreported
occurrence, Hum. Pathol. 13 (2003) 1061e1065.
[30] V. Hervieu, C. Lombard-Bohas, J. Dumortier, O. Boillot, J.Y. Scoazec, Primary
acinar cell carcinoma of the liver, Virchows Arch. 13 (2008) 337e341.
[31] A. Ambrosini-Spaltro, O. Potì, M. De Palma, M. Filotico, Pancreatic-type acinar
cell carcinoma of the stomach beneath a focus of pancreatic metaplasia of the
gastric mucosa, Hum. Pathol. 13 (2009) 746e749.
[32] A. Agaimy, A. Kaiser, K. Becker, et al., Pancreatic-type acinar cell carcinoma of
the liver: a clinicopathologic study of four patients, Mod. Pathol. 13 (2011)
1620e1626.
[33] A. Pesci, P. Castelli, E. Facci, L. Romano, G. Zamboni, Primary retroperitoneal
acinar cell cystadenoma, Hum. Pathol. 13 (2012) 446e450.
[34] C. Reyes, M. Jorda, C. Gomez-Fernandez, Salivary gland-like tumors of the
breast express basal-type immunohistochemical markers, Appl. Immunohis-
tochem. Mol. Morphol. 21 (4) (2013 Jul) 283e286.
[35] A. Tortoriello, G. Facchini, F. Caponigro, et al., Phase I/II study of paclitaxel and
vinorelbine in metastatic breast cancer, Breast Cancer Res. Treat. 47 (1) (1998
Jan) 91e97.
[36] Salarieh, N. Sneige, Breast carcinoma arising in microglandular adenosis: a
review of the literature, Arch. Pathol. Lab. Med. 131 (9) (2007 Sep)
1397e1399.
[37] I.M.1 Khalifeh, C. Albarracin, L.K. Diaz, et al., Clinical, histopathologic, and
immunohistochemical features of microglandular adenosis and transition
into in situ and invasive carcinoma, Am. J. Surg. Pathol. 32 (4) (2008 Apr)
544e552.
